Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice (Q46618830)
Jump to navigation
Jump to search
scientific article published on 23 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice |
scientific article published on 23 May 2013 |
Statements
1 reference
Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice (English)
1 reference
Atsuo Tahara
1 reference
Eiji Kurosaki
1 reference
Masanori Yokono
1 reference
Daisuke Yamajuku
1 reference
Rumi Kihara
1 reference
Yuka Hayashizaki
1 reference
Toshiyuki Takasu
1 reference
Masakazu Imamura
1 reference
Qun Li
1 reference
Hiroshi Tomiyama
1 reference
Yoshinori Kobayashi
1 reference
Atsushi Noda
1 reference
Masao Sasamata
1 reference
Masayuki Shibasaki
1 reference
23 May 2013
1 reference
1 reference
715
1 reference
1-3
1 reference
246-255
1 reference
Identifiers
1 reference
1 reference